Released: Last reviewed:
One current methodology governs provider scoring, ranking tables, FAQ answers, datasets, and llms files.
| Category | Weight |
|---|---|
| Pricing transparency | 20% |
| Total annual cost | 20% |
| Clinical oversight | 15% |
| Pharmacy transparency | 15% |
| Support | 10% |
| Regulatory disclosure | 10% |
| Accessibility | 10% |
A provider is ranked in the verified standard-injection affordability table only when its complete 12-month all-in standard-injection cost can be verified from a standing public source.
A starting price multiplied by twelve is labeled a floor, not a verified annual total, unless the provider confirms on a standing public page that the price remains applicable across covered doses and that required fees and included services are disclosed.
Dr. Parmis serves as Editorial Lead. Dr. Jonathan Snipes, MD (NPI 1821250077) serves as Medical Reviewer, and Kim Callender, NP (FNP-BC, NPI 1144661760) serves as Lead Reviewer. Provider representatives have no editorial role in provider evaluations.
TirzepatideReview.com is published by Ronika Partners LLC and is affiliate-supported. The publisher may receive compensation when readers enroll through certain provider links. Providers cannot purchase placement or alter a score. Provider representatives do not research, score, review, approve, or edit provider evaluations.
Send documented corrections to corrections@tirzepatidereview.com. We target review within five business days and update material errors when verified.
Medical note: The site is educational and does not provide medical care. Compounded medications are not FDA-approved drug products. Treatment decisions require evaluation by a licensed clinician.